Targeting Go and Grow in Glioblastoma
Targeting Go and Grow in Glioblastoma
批准号:
10246514
负责人:
Peter Canoll
金额:
$59.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-06-30
关键词:
AddressApoptosisAutomobile DrivingBrainCategoriesCellsComplexDevelopmentDiseaseDoseEnvironmentEpidermal Growth Factor ReceptorFamilyFamily memberGeneticGenetically Engineered MouseGlioblastomaGoalsGrowthHumanImpairmentIn VitroInvadedKnock-outMeasuresMechanicsMethodsMolecular MotorsMonitorMusMyosin Type IINewly DiagnosedNonmuscle Myosin Type IIAParalysedPathway interactionsPermeabilityPharmaceutical PreparationsPhenotypePolyploidyPopulationProliferatingProtein IsoformsRadiationRadiosensitizationResistanceRestSignal PathwaySignal TransductionSliceTestingTherapeuticThickTissuesToxic effectTranslatingUp-Regulationeffective therapyfallsin vivoinhibitor/antagonistmalignant phenotypemouse modelnon-muscle myosinnovelphosphoproteomicsresponsesingle-cell RNA sequencingsmall hairpin RNAsmall molecule inhibitortranscriptome sequencingtranslational studytumortumor growthtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT DESCRIPTION
The ability of glioblastomas to proliferate in an uncontrollable manner and disperse widely within normal brain
define the malignant phenotype and make this disease uniformly lethal. Effectively treating glioblastoma
therefore requires finding targets that drive these two components of the malignant phenotype. We have
identified one such target—the myosin II family of molecular motors. We show that myosin II family members
can be targeted with a non-toxic small molecule inhibitor that is CNS permeant, and that this drug suppresses
tumor progression and significantly prolongs survival in murine models of glioblastoma. However, we also find
that targeting myosin II family members leads to a compensatory upregulation of a variety of proliferation-
stimulating signaling pathways, and that inhibiting these pathways is synthetically lethal when myosin II function
is blocked. In this proposal, we will develop strategies to enhance the efficacy of a myosin II targeting strategy
in treating glioblastoma that build on our novel findings. Results from these translational studies will be vital to
our ongoing efforts to develop effective treatment approaches that block both glioblastoma invasion and
proliferation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
-
批准号:10729420
-
项目类别:
-
资助金额:$208.67万
-
财政年份:2023
-
负责人:Peter Canoll
-
依托单位:
Single Nucleus Transcriptional Profiling of Intractable Focal Epilepsy
-
批准号:10544524
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2022
-
负责人:Peter Canoll
-
依托单位:
Single Nucleus Transcriptional Profiling of Intractable Focal Epilepsy
-
批准号:10373149
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2022
-
负责人:Peter Canoll
-
依托单位:
Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10361416
-
项目类别:
-
资助金额:$81.49万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Langworthy Diversity Supplement: Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10381307
-
项目类别:
-
资助金额:$4.61万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Diversity Supplement Ifediora: Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10746512
-
项目类别:
-
资助金额:$8.13万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10737767
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10580715
-
项目类别:
-
资助金额:$65.47万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Image-based models of tumor-immune dynamics in glioblastoma
-
批准号:10524208
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2021
-
负责人:Peter Canoll
-
依托单位:
Targeting Go and Grow in Glioblastoma
-
批准号:10650328
-
项目类别:
-
资助金额:$58.75万
-
财政年份:2020
-
负责人:Peter Canoll
-
依托单位:
Targeting Go and Grow in Glioblastoma
-
批准号:10053146
-
项目类别:
-
资助金额:$57.38万
-
财政年份:2020
-
负责人:Peter Canoll
-
依托单位:
Targeting Go and Grow in Glioblastoma
-
批准号:10439805
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2020
-
负责人:Peter Canoll
-
依托单位:
Mechanism of regulation of progenitor proliferation and transformation
-
批准号:9769907
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2017
-
负责人:Peter Canoll
-
依托单位:
Mechanism of regulation of progenitor proliferation and transformation
-
批准号:10016389
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2017
-
负责人:Peter Canoll
-
依托单位:
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
-
批准号:10083766
-
项目类别:
-
资助金额:$56.06万
-
财政年份:2017
-
负责人:Peter Canoll
-
依托单位:
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
-
批准号:9566311
-
项目类别:
-
资助金额:$57.45万
-
财政年份:2017
-
负责人:Peter Canoll
-
依托单位:
Glioma induced alterations in neuronal transcription and translation
-
批准号:8920180
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2014
-
负责人:Peter Canoll
-
依托单位:
Molecular Motors and Glioma Dispersion
-
批准号:8730238
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2012
-
负责人:Peter Canoll
-
依托单位:
Molecular Motors and Glioma Dispersion
-
批准号:8539857
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2012
-
负责人:Peter Canoll
-
依托单位:
Molecular Motors and Glioma Dispersion
-
批准号:8438054
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2012
-
负责人:Peter Canoll
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: